These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17229172)

  • 1. Stroke risk stratification in atrial fibrillation: something to EXAMINE more closely.
    Watson T; Kakar P; Lip GY
    Int J Clin Pract; 2007 Jan; 61(1):6-9. PubMed ID: 17229172
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk factors and stroke risk stratification for atrial fibrillation: limitations and new possibilities.
    Lip GY
    Am Heart J; 2008 Jul; 156(1):1-3. PubMed ID: 18585489
    [No Abstract]   [Full Text] [Related]  

  • 3. [Thromboembolic risk in atrial fibrillation: new clinical perspectives].
    Villani GQ; Andreoli AM; Villani M; Capucci A
    G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):22S-26S. PubMed ID: 19195302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
    Mant JW
    Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
    [No Abstract]   [Full Text] [Related]  

  • 5. Confronting atrial fibrillation in the elderly: stroke risk stratification and emerging antithrombotic therapies.
    Strong SH; Halperin JL
    Geriatrics; 2007 Mar; 62(3):22-7. PubMed ID: 17346095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paroxysmal atrial fibrillation, stroke risk and thromboprophylaxis.
    Lip GY
    Thromb Haemost; 2008 Jul; 100(1):11-3. PubMed ID: 18612530
    [No Abstract]   [Full Text] [Related]  

  • 7. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 8. Atrial fibrillation and stroke severity: expanding the mechanistic exemplar, clinical phenotype, and goals of anticoagulant pharmacotherapy.
    Hylek EM; Becker RC
    Ann Neurol; 2008 Nov; 64(5):480-3. PubMed ID: 19067369
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticoagulation: stroke prevention in patients with atrial fibrillation.
    Waldo AL
    Med Clin North Am; 2008 Jan; 92(1):143-59, xi. PubMed ID: 18061002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT study.
    Ip J; Waldo AL; Lip GY; Rothwell PM; Martin DT; Bersohn MM; Choucair WK; Akar JG; Wathen MS; Rohani P; Halperin JL;
    Am Heart J; 2009 Sep; 158(3):364-370.e1. PubMed ID: 19699858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stroke prevention in atrial fibrillation--pharmacologic strategies.
    Tiyyagura SR; Goldbarg SH; Mehta D
    Indian Heart J; 2007; 59(4):311-5. PubMed ID: 19126935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing the challenge of atrial fibrillation and stroke prevention in older people: new drugs or new approaches to improve outcomes?
    Fuller R; Dudley N
    Age Ageing; 2005 Jul; 34(4):413-4; author reply 414. PubMed ID: 15955767
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
    Själander A; Wallentin L; Rosenqvist M; Svensson P
    Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
    [No Abstract]   [Full Text] [Related]  

  • 14. Anticoagulation for elderly patients with atrial fibrillation: not to be neglected.
    Taggar JS; Lip GY
    Europace; 2008 Jan; 10(1):1-2. PubMed ID: 17906285
    [No Abstract]   [Full Text] [Related]  

  • 15. Stroke risk in atrial fibrillation patients on warfarin. Predictive ability of risk stratification schemes for primary and secondary prevention.
    Poli D; Antonucci E; Grifoni E; Abbate R; Gensini GF; Prisco D
    Thromb Haemost; 2009 Feb; 101(2):367-72. PubMed ID: 19190823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China.
    Hu D; Sun Y
    J Am Coll Cardiol; 2008 Sep; 52(10):865-8. PubMed ID: 18755352
    [No Abstract]   [Full Text] [Related]  

  • 17. Atrial fibrillation and stroke: risk stratification and new anticoagulants.
    Jazra C; Khoury M
    J Med Liban; 2013; 61(2):109-12. PubMed ID: 24163898
    [No Abstract]   [Full Text] [Related]  

  • 18. Anticoagulant-related bleeding risk in older persons: unfounded fears?
    Pechlaner C
    Arch Intern Med; 2004 Jan; 164(1):106-7; author reply 107. PubMed ID: 14718333
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anticoagulation in atrial fibrillation].
    Binggeli C; Brunckhorst CB
    Herz; 2008 Feb; 33(1):13-9. PubMed ID: 18273573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ablation for atrial fibrillation: can we decrease thromboembolism without increasing the risk for bleeding?
    Asirvatham SJ
    Circulation; 2007 Nov; 116(22):2517-9. PubMed ID: 18040036
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.